Open AccessSystemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Author(s) -
Stefanie Zimmermann,
Peggy Sekula,
Moritz Venhoff,
Edith Motschall,
Jochen Knaus,
Martin Schumacher,
Maja Mockenhaupt
Publication year - 2017
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2016.5668
Subject(s) - medicine , toxic epidermal necrolysis , medline , cochrane library , thalidomide , intensive care medicine , meta analysis , dermatology , political science , law , multiple myeloma
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are rare but severe adverse reactions with high mortality. There is no evidence-based treatment, but various systemic immunomodulating therapies are used.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom